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Jack B. Hicks 
A licensed patent attorney with more than 25 years of legal experience, 
Jack Hicks counsels clients to craft the intellectual property position 
that meets their business goals. A substantial portion of his practice 
includes the preparation and prosecution of U.S. and foreign patent 
and trademark applications. Although Jack started his career as a 
successful trial lawyer, his practice currently focuses upon strategic 
counseling of clients in national and international intellectual property 
litigation, evaluation, protection and enforcement. Jack’s honors and 
awards include being ranked among the leading lawyers in his field by 
The Best Lawyers in America, North Carolina Super Lawyers and 
North Carolina Legal Elite.  
  
Jack currently is working with numerous nanotechnology clients, 
helping them prepare and prosecute patents and other suitable 
intellectual property protection.  One recent matter involved preparing 
and filing multiple U.S. and international patent applications for a 
leading aerospace manufacturer on the use of carbon nanotubes in 
coatings and complex composite structures.  Other projects include 
nanofibers for drug delivery and filter technologies. 
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John Parker Sweeney 
Class Actions and Mass Torts often involve “bet the company” risks. John Parker Sweeney’s 
more than 30 years of experience defending major Class Actions and Mass Torts involving 
Product Liability, Consumer Protection, Environmental, and Toxic Tort cases allows him to 
tailor an appropriate litigation response for any company to meet those types of high stakes 
risks. He regularly serves as national counsel, creating and supervising comprehensive 
defense strategies in Class Actions and Mass Tort cases across the country.   
  
John’s effectiveness and national prominence as a defense lawyer for businesses in Class 
Actions and Mass Torts was recognized by his peers when he was elected as an officer of 
DRI—The Voice of the Defense Bar. John will serve as President of the 22,000 member 
association of corporate defense lawyers in 2014. 
  
A nationally-recognized "Expert on Experts," John relies on his relationships with internationally 
renowned technical, scientific, and medical experts, as well as his thorough understanding of 
the rules and procedures governing expert testimony in both Daubert and Frye jurisdictions to 
protect his clients from scientifically unfounded claims and unqualified plaintiffs' experts, 
securing precedent-setting decisions excluding junk science from the courtroom.  
  
John has many years of experience in Government Investigation work beginning with his years 
at the U.S. Securities Exchange Commission. Since then, in addition to responding to SEC 
investigations, he has been involved in investigations and other compliance actions involving a 
number of federal and state law enforcement agencies. He is particularly experienced in 
handling Consumer Product Safety reporting, recalls and corrective actions before the U.S. 
Consumer Product Safety Commission, and in advising clients on compliance with the far-
reaching new requirements of the Consumer Product Safety Improvement Act of 2008 and the 
Consumer Product Safety Information Database. 
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EXPANDED ROLE OF 
PATENTS 
Patent is a commoditized asset, 
aggregated for profit 
Patent is a tool to encourage innovation 
and prevent trespass on your invention 
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What is a 
Non-practicing Entity? 
 
Troll? 
 
Is a University a Troll? 
9 
• Patent troll claims rights to an invention 
without commercializing 
• Non-practicing entity (NPE) who 
engages in “stick” licensing 
• Patent holding & licensing entities 
• “Invention research organization” 
• University Tech Transfer Office 
• Government Research Organization 
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Assertion: 
• You are using our patented technology 
• Take a license or face litigation 
• Legal fees for infringement study:  $5,000-$20,000 
per patent 
• Legal fees for patent litigation:  $1.5M-$5.0M 
• Settle:  $10,000 - $150,000 
YOU 
Entity 
US Patent 
Publications 
Patent 
Families 
Intellectual Ventures 10-15k (Est) - 
Round Rock Research LLC 3652 1300 
Rockstar Consortium LLC 3428 2867 
Interdigital 2955 1463 
Wisconsin Alumni Research Foundation (WARF) 2556 1896 
Mosaid Technologies Inc 2011 1219 
Rambus 1696 727 
Tessera Technologies Inc 1375 683 
Acacia Technologies 1316 575 
Commonwealth Scientific and Industrial 
Research Organisation (CSIRO) 
1160 935 
IPG Healthcare 501 Limited 1141 1074 
Walker Digital LLC 896 222 
Wi-Lan 888 716 
Jerome H Lemelson 470 227 
NPEs with Largest Patent Holdings 
Source: PatentFreedom © 2012. Data captured as of July 13, 2012. 
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• Acacia Technologies 
• Asure Software 
• Burst.com Inc 
• Decisioning.com Inc 
• Interdigital 
• Intertrust Technologies 
Corp 
• LecTec Corp 
 
* The Private and Social Costs of Patent Trolls, Boston University School of Law Working Paper No. 11-45 (September 
19, 2011) Revision of November 9, 2011 
• Mosaid Technologies Inc 
• Network-1 Security Solutions 
Inc 
• OPTi Inc 
• Rambus 
• Tessera Technologies Inc 
• VirnetX Inc 
• Wi-Lan 
Public NPE firms 
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Industry 
Operating 
Company 
Counterparties 
in NPE Patent 
Litigations 
Unique Operating 
Companies in NPE 
Patent Litigations 
NPEs in 
Patent 
Litigations 
NPE 
Patent 
Litigati
ons 
NPE 
Litigate
d 
Patents 
Electronics13 3198 549 328 1646 1434 
Retail 3116 912 289 1259 901 
Media/Telecom 2591 708 274 1345 993 
Computer 
Software/Services 
2476 966 316 1401 1253 
Computer 
Hardware 
2262 334 324 1278 1362 
Financial Services 1681 596 170 730 512 
Automotive & 
Transport 
1599 525 145 685 492 
Consumer Products 1032 446 178 549 413 
Semiconductor 872 142 133 467 527 
Industrial 
Manufacturing 
681 338 193 465 552 
Healthcare & 
Pharma 
603 363 83 284 210 
Energy/Utilities 536 282 140 383 344 
Other (Hotels, 
Services, 
Agriculture etc.) 
1638 823 267 944 763 
NPE Patent 
Litigation 
Statistics by Industry 
 
 
Source: PatentFreedom © 2012. Data 
captured as of August 21, 2012. 
Litigations Over Time 
Patent lawsuits involving NPEs have increased dramatically over the last 
decade. In 2011, another record setting year, there were more than 5,000 
occasions when a company found itself in litigation with an NPE, a number that 
has increased by an average of over 35% per year since 2004.  
Source: PatentFreedom © 2012. Data captured as of July 13, 2012. 
Operating Company Parties in NPE Lawsuits 
Source: PatentFreedom © 2012. Data captured as of July 13, 2012. 
Patent Lawsuits Involving NPEs 
Litigations Over Time 
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Nano and Patents?  
What’s Special? 
Universities owning patents 
• Basic research centered in Universities & 
spin-outs 
• Universities/tech transfer offices push 
patents 
• Bayh-Dole Act (1980) permits University 
ownership of federally funded research 
17 
Is There “Room at the Bottom”? 
Feynman, Richard P, There's Plenty of Room at the Bottom, Caltech Engineering and Science Magazine (1960) 
U.S. Patent 
Number Date of Issue Owner Title 
6,683,783 January 27, 2004 William Marsh Rice University 
Houston, TX 
Carbon fibers formed from single-wall carbon 
nanotubes  
5,747,161 May 5, 1998 NEC Corporation Graphite filaments having tubular structure and 
methold of forming the same  
5,424,054 June 13, 1995 International Business Machines 
Corporation 
Carbon fibers and method for their production  
5,505,928 April 9, 1996 The Regents of University of California Preparation of iii-v semiconductor nanocrystals  
6,268,041 July 31, 2001 Starfire Electric Development and 
Marketing, Inc. 
Narrow size distribution silicon and germanium 
nanocrystals  
6,322,901 November 27, 2001 Massachusetts Institute of Technology Highly luminescent color-selective nano-
crystalline materials  
5,897,945 April 27, 1999 
President and Fellows of Harvard 
College Metal oxide nanorods  
5,833,705 November 10, 1998 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils  
4,724,318 February 9, 1998 International Business Machines 
Corporation 
Atomic force microscope and method for 
imaging surfaces with atomic resolution  
5,286,571 February 15, 1994 Northwestern University  Molecular modification reagent and method to 
functionalize oxide surfaces  
6,346,189 February 12, 2002 The Board of Trustees of the Leland 
Stanford Junior University 
Carbon nanotube structures made using catalyst 
islands  
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William Marsh 
Rice University 
 Carbon Fibers Formed From 
Single-Wall Carbon Nanotubes 
US 6,683,789 
Filed: 3/6/1998 
Issued: 1/27/2004 
 
“semiconducting nanocrystals” 
19 
A composition of 
matter comprising 
at least about 99% 
by weight of 
single-wall carbon 
molecules. 
 
William Marsh 
Rice University 
 Carbon Fibers Formed From 
Single-Wall Carbon Nanotubes 
US 6,683,789 
Filed: 3/6/1998 
Issued: 1/27/2004 
 
(19 claims) 
20 
Can you prepare? How? 
• Core Products - Prior Art Searching 
• Obtaining patents for trade 
• Patentability … AND 
• Freedom to Operate to identify licensors/predators 
• Build license royalty into business plan 
• Join patent pool organization 
 • Ancillary Businesses 
• Use solvent contractors / suppliers who 
indemnify 
• Insurance … ? 
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What to do when you receive a 
demand letter? 
• Gather information on NPE’s patterns & 
strategies 
• Assess strength of claim, underlying IP, exposure 
and indemnity  
• Defenses 
Prior Commercial Use; laches 
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Fight or Settle? 
• File preemptive declaratory judgment lawsuit in 
home district; early claim construction and 
summary judgment ($$) 
• File post-grant review ($$) 
• Joint defense groups 
• Crowd sourcing for invalidating prior art (Article 
One Partners) 
• Defensive Patent Aggregation (RPX; Allied Security Trust) 
23 
Is “help” on the way?  What 
can Congress do? 
• Transferability of Patents and Non-
working Requirement are Hallmarks of 
US Patent System 
• America Invents Act  
 Joinder rules 
 Post-grant  review proceeding for covered business  
method patents.  
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Is “help” on the way?  What 
can Congress do? 
• Recent legislation – HR 6245 Saving High-
Tech Innovators from Egregious Legal 
Disputes Act (Shield Act) 
Fee-shifting / “loser pays” for computer 
hardware & software patent litigation where no 
“ reasonable likelihood of succeeding” 
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Nanotechnology Is in the 
News 
28 
BUT NOT 
ALL THE 
NEWS IS 
GOOD 
Ken Donaldson, professor of 
respiratory toxicology at the 
University of Edinburgh, said: 
"Concern has been expressed that 
new kinds of nanofibers being made 
by nanotechnology industries might 
pose a risk because they have a 
similar shape to asbestos." 
30 
    “Inhaling tiny fibers 
made by the 
nanotechnology 
industry could cause 
similar health problems 
to asbestos,” say 
researchers. 
 
“Nanofibers 'may pose health 
risk‘” 
1,000 times smaller than a 
human hair 
31 
Earlier Studies Made 
the Same Comparison 
 
… results in asbestos-like, length-
dependent, pathogenic  
behaviour.” 
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"We knew that long fibres, compared with shorter fibres, could 
cause tumours, but until now we did not know the cut-off length 
at which this happened.” 
 
"This research is particularly interesting as it gives us an indication 
of the size of fibre that might lead to mesothelioma if inhaled.” 
 
"If confirmed by subsequent studies, this minimum fibre length can 
be cited in industry guidelines to help ensure people are not 
exposed to the sorts of fibres that may lead to such deadly 
diseases." 
Carcinogenicity Is Assumed 
What About Asbestos Litigation? 
Rumors of Its Death Are 
Premature, but . .  . 
Everyone Is Looking for the 
Next Asbestos 
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Research Continues… 
37 
Will Nanomaterials Be Tarred 
with the Asbestos Brush? 
38 
The Comparison 
Is Easily Made 
… results in asbestos-like, length-
dependent, pathogenic  
behaviour.” 
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The Literature Stacks Up 
• Exposure to nanoparticles 
is related to pleural 
effusion, pulmonary fibrosis 
and granuloma.  
• Song, et al. European 
Respiratory Journal (Sept. 
2009) 
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Soybean susceptibility to manufactured 
nanomaterials with evidence for food quality 
and soil fertility interruption 
Risk perception and risk communication 
with regard to nanomaterials in the 
workplace 
 
ISO Preparing Labeling Guidance for 
Manufactured Nano-Objects and Products 
Containing Manufactured Nano-Objects SCENIHR Issues Call for Information and 
Experts on Health Effects of 
Nanomaterials Used in Medical Devices 
Safety Concerns Abound 
SCCS Calls for Experts on the 
Safety Assessment of 
Nanomaterials in Cosmetic 
Products 
FDA Directed to Study Nanomaterials 
 
On July 9, 2012, the Food and Drug Administration Safety and 
Innovation Act became law, charging the Secretary of Health and 
Human Services to “intensify and expand activities related to 
enhancing scientific knowledge regarding nanomaterials included 
or intended for inclusion in products regulated” by FDA. 
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Regulation is Coming Slowly 
43 
Industry Safety Assurances 
Get Little Media Attention 
44 
… The Nanodermatology Society believes that nano-
based sunscreens do not pose serious health risks to 
consumers…  
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Potential Areas of 
Liability Concern 
• “Occupational” Claims 
 
• “Consumer” Claims 
  
• “Environmental” Claims 
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Worker Exposure Is a 
Concern 
Health scare: Labor unions claim that 
workers in the nanotechnology sector 
might be facing a health “time bomb “ 
The July 3, 2012 National Institute for Occupational Safety 
and Health (NIOSH) eNews nanotechnology update states that 
the critical question to address is whether nanomaterials pose 
health or safety risks to workers employed in their 
manufacture and industrial use. 
47 
Consumer Health Concerns  
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According to a 
USDA scientist, 
some Latin 
American packers 
spray U.S.-bound 
produce with a 
wax-like 
nanocoating to 
extend shelf-life. 
"We found no 
indication that the 
nanocoating ... has 
ever been tested for 
health effects,"  
Despite FDA Denials, Nano-Food Is Here  
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Environmental Concerns  
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A Cautionary Tale 
1960s 
The first silicone breast implants are developed by two plastic surgeons from Texas. 
 
January 1982 
FDA proposes to classify silicone breast implants into a Class III category which 
would require manufacturers to prove their safety in order to keep them on the market. 
1976 
FDA now has the authority to approve new medical devices. But since silicone breast 
implants have been on the market for almost 15 years, they are "grandfathered.” 
1980s 
Ralph Nader's Public Citizen Health Research Group, Washington, D.C. sends out 
warning signals that silicone breast implants cause cancer. 
December 1990 
Program on the dangers of silicone breast implants airs on "Face to Face with Connie 
Chung." 
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December 1991 
The largest tort award yet, $7.3 million, is given to Mariann Hopkins whose mixed 
connective- tissue disease is linked to her ruptured silicone breast implants. To date, 137 
individual lawsuits have been filed against Dow Corning. 
January 1992 
FDA Commissioner, David Kessler, calls for a voluntary moratorium on silicone breast 
implants until the FDA and the advisory panel have an opportunity to consider newly 
available information. The manufacturers agree. 
December 1992  
Pamela Jean Johnson wins $25 million tort award in Houston. To date 3,558 individual 
lawsuits have been filed against Dow Corning. 
March 1992 
Dow Corning leaves the silicone breast implant business  
March 1994 
A class action settlement is reached with Dow Corning being the largest contributor. 
Manufacturers claim there is no scientific evidence linking silicone breast implants 
with autoimmune diseases 
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June 1999 
The Institute of Medicine releases a 400-page report concluding that silicone breast 
implants do not cause any major diseases such as lupus or rheumatoid arthritis.  
December 1998 
A panel of four independent experts appointed by Judge Sam C. Pointer, overseer 
of implant lawsuits in the Federal courts, concludes that scientific evidence so far 
has failed to show that silicone breast implants cause disease. 
 
November 1998 
Dow Corning files for bankruptcy reorganization, which includes the $3.2 billion 
previously agreed-to settlement and offers claimants several payout options. 
September 1997 
The Journal of the National Cancer Institute publishes a review of scores of 
medical studies that concludes breast implants do not cause breast cancer. The 
researchers described the evidence for linking implants to any other disease as 
"borderline." 
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            Due Diligence  
•Is the company’s IP 
solid? 
 
•What are the 
potential regulatory 
hurdles? 
 
•What are the 
potential liabilities? 
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LOOK BEFORE YOU LEAP 
56 
Questions, 
Comments and Concerns 
 
Thank you 
